A trio of up-and-coming Chinese tech companies are now "waiting in the pipeline" for public listings, said an investment bank executive. » Read More
By: Elizabeth Cheung
A chilled chicken sample from China found containing a bird flu virus was sold by a Hong Kong vendor, SCMP reports. » Read More
By: Christina Farr
Practice Fusion was struggling to grow and looking for an acquirer even as it was projecting optimism to employees and the public. » Read More
Aetna will pay a civil fine and improve its privacy practices to settle charges it leaked the HIV-positive status of 2,460 New York members. » Read More
Mayor Bill de Blasio said the lawsuit seeks $500 million of damages to help fight the epidemic in the city.
Johnson & Johnson took hit from the new tax law but will see a lower effective rate because of the changes.
Johnson & Johnson shares slipped Tuesday after the company clarified its forecast for the year.
The declining birth rate in the U.S. is hurting some of the country's biggest consumer companies.
The health insurance tax is delayed a year, while the medical device and Cadillac taxes are delayed two years.
Drugmakers' response to the rise of drug-resistant bacteria remains patchy, even after years of warnings.
A U.S. appeals court upheld a ruling that invalidated a crucial Johnson & Johnson patent on its blockbuster rheumatoid arthritis drug.
President Trump's tweets about North Korea and nuclear war have led to a surge in online sales of radiation pills. Do they work?
Johnson & Johnson topped Wall Street's revenue and earnings expectations.
Jim Cramer broke down why he thinks the IPO market has been slim pickings amidst the current bull market.
Jim Cramer did a deep dive into the market's strongest sectors, including tech and the banks, to find the best investments in each space.
As use of illegal opioids such as heroin and fentanyl has increased, so has the number of fatal overdoses in West Virginia.
The Children's Health Insurance Program became a bargaining chip in larger negotiations over the federal budget & immigration, Vox reports.
A new study shows a lower health-care spending burden among low-income groups, but an increase in that burden among higher earners.
Three weeks into 2018, deal activity in the biotech sector is already almost halfway to what it was in 2017, at least in terms of size.
Scientists are trying to develop flu shots that are more effective than the ones on the market today.
Get the best of CNBC in your inbox